Syndax Pharmaceuticals, Inc. (SNDX) Stock Total Returns
Growth of $10,000 chart
2021-06-03 to 2026-06-03 to
$
%
%
Loading chart…
Investment Performance
Final Value
$10,240
Total Return
2.40%
CAGR
0.48%
Dividends
$0.00
Yield on Cost
0.00%
Rolling Returns
1-Month (21 Trading Days)
| Average | +1.31% |
| Median | -0.99% |
| Best | +67.76% |
| Worst | -35.90% |
| % of Windows Positive | 47.2% |
1-Year (252 Trading Days)
| Average | +6.81% |
| Median | +5.18% |
| Best | +131.27% |
| Worst | -61.87% |
| % of Windows Positive | 55.8% |
3-Year (756 Trading Days)
| Average | -12.95% |
| Median | -14.80% |
| Best | +71.74% |
| Worst | -54.52% |
| % of Windows Positive | 26.9% |
Risk Metrics
| Maximum Drawdown | -69.88% |
| Average Drawdown | -29.28% |
| Drawdown Duration | 835 Trading Days (Unrecovered) |
| Sortino Ratio | 0.41 |
| Calmar Ratio | 0.01 |
| CVaR (5%) | -7.36% |
Yearly Returns
| Year | Percentage | Abs. Return | Dividends | Taxes | Trans. Costs |
|---|---|---|---|---|---|
| 2026 partial | -12.71% (-27.56% ann.) | $1270.82 | $0.00 | $0.00 | $0.00 |
| 2025 | +58.93% | +$5892.58 | $0.00 | $0.00 | $0.00 |
| 2024 | -38.82% | $3882.46 | $0.00 | $0.00 | $0.00 |
| 2023 | -15.09% | $1508.84 | $0.00 | $0.00 | $0.00 |
| 2022 | +16.26% | +$1626.31 | $0.00 | $0.00 | $0.00 |
| 2021 | -1.57% | $157.37 | $0.00 | $0.00 | $0.00 |
| 2020 | +153.30% | +$15330.28 | $0.00 | $0.00 | $0.00 |
| 2019 | +97.30% | +$9730.36 | $0.00 | $0.00 | $0.00 |
| 2018 | -49.20% | $4920.10 | $0.00 | $0.00 | $0.00 |
| 2017 | +22.18% | +$2217.57 | $0.00 | $0.00 | $0.00 |
| 2016 partial | -40.25% (-46.25% ann.) | $4025.00 | $0.00 | $0.00 | $0.00 |
Market Regimes
about| Regime | Period | Percentage | Annual | Abs. Return | Dividends | Taxes | Trans. Costs |
|---|---|---|---|---|---|---|---|
| Secular stagnation / QE / low inflation / duration bull partial | March 2, 2016 – February 19, 2020 | -13.08% | -3.47% | $1308.33 | $0.00 | $0.00 | $0.00 |
| Pandemic shock / liquidity crash | February 20, 2020 – March 23, 2020 | -16.73% | -87.62% | $1672.76 | $0.00 | $0.00 | $0.00 |
| Policy bazooka / monetary euphoria | March 24, 2020 – November 6, 2020 | +107.21% | +222.94% | +$10721.35 | $0.00 | $0.00 | $0.00 |
| Reopening reflation / fiscal boom / supply bottlenecks | November 9, 2020 – November 29, 2021 | -20.39% | -19.46% | $2039.18 | $0.00 | $0.00 | $0.00 |
| Inflation shock / duration crash / aggressive tightening | November 30, 2021 – November 9, 2022 | +47.03% | +50.57% | +$4702.57 | $0.00 | $0.00 | $0.00 |
| Disinflation rebound / AI-led narrow bull / higher-for-longer | November 10, 2022 – September 17, 2024 | -23.12% | -13.22% | $2311.62 | $0.00 | $0.00 | $0.00 |
| Disinflationary easing / resilient growth / AI capex under oil-shock test partial | September 18, 2024 – June 3, 2026 | +1.89% | +1.10% | +$188.89 | $0.00 | $0.00 | $0.00 |
Dividend History
| Date | Per Share | Yield % |
|---|---|---|
| Total | 0 payments |
No dividends recorded.
All calculations use split-adjusted closing prices. Dividends are reinvested on the ex-dividend date at that day's closing price.
For each rolling window, returns are calculated at every possible starting point:
return = (value[i] ÷ value[i − windowSize] − 1) × 100
- Windows
- 1-month = 21 trading days, 1-year = 252 trading days, 3-year = 756 trading days.
- Statistics
- Average: arithmetic mean. Median: middle value when sorted. Best / Worst: max and min. % Positive: share of windows with return > 0.
The series is segmented by calendar year:
return = (endValue ÷ startValue − 1) × 100
startValue is the last value of the prior year (or the first value for the initial year). Partial first/last years are flagged. Dividends, taxes, and transaction costs are scaled proportionally to the initial investment.